Skip to main content
Top
Published in: Journal of Neuro-Oncology 3/2011

01-05-2011 | Laboratory Investigation - Human/Animal Tissue

Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population

Authors: Nitin Malik, Raj Kumar, Kashi N. Prasad, Priyanka Kawal, Arun Srivastava, Ashok K. Mahapatra

Published in: Journal of Neuro-Oncology | Issue 3/2011

Login to get access

Abstract

Matrix metalloproteinase-1 (MMP-1) is known to be involved in the pathogenesis of glioma. It damages the extra-cellular matrix to produce invasiveness in cancer tissue, and hence has a direct effect in cancer invasion. The study aims to explore the association of single nucleotide polymorphism of -1607 MMP-1 gene with susceptibility to glioblastoma multiforme (GBM) in northern Indian subjects. One hundred and ten GBM patients and 150 healthy controls were included in this study. 1607 MMP-1 gene was studied by PCR–RFLP; different genotypes being combinations of 1G and 2G allele (1G/1G, 1G/2G and 2G/2G). 2G/2G genotype was significantly associated with GBM patients (OR, 2.24; P = 0.016; 95% CI, 1.16–4.30) as compared to controls. Prevalence of the 2G allele of -1607 MMP-1 polymorphism was significantly greater in GBM patients as compared to controls (62.3 vs 48.3%, OR, 1.76; P = 0.002; 95% CI, 1.23–2.52). This study suggests that the 2G/2G genotype and 2G allele of -1607 MMP-1 polymorphism are associated with an increased susceptibility for developing GBM.
Literature
1.
go back to reference CBTRUS (2009) Statistical report: primary brain tumors in the United States, 2004–2005 CBTRUS (2009) Statistical report: primary brain tumors in the United States, 2004–2005
2.
go back to reference Phatak P, Selvi SK, Divya T, Hegde AS, Hegde S, Somasundaram K (2002) Alterations in tumour suppressor gene p53 in human gliomas from Indian patients. J Biosci 27:673–678PubMedCrossRef Phatak P, Selvi SK, Divya T, Hegde AS, Hegde S, Somasundaram K (2002) Alterations in tumour suppressor gene p53 in human gliomas from Indian patients. J Biosci 27:673–678PubMedCrossRef
3.
go back to reference Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY (2003) Primary brain tumours in adults. Lancet 361:323–331PubMedCrossRef Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY (2003) Primary brain tumours in adults. Lancet 361:323–331PubMedCrossRef
4.
go back to reference Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio MC (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol 15:535–541PubMedCrossRef Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio MC (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol 15:535–541PubMedCrossRef
5.
go back to reference Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174PubMedCrossRef Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174PubMedCrossRef
6.
go back to reference Cauwe B, Van den Steen PE, Opdenakker G (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42:113–185PubMedCrossRef Cauwe B, Van den Steen PE, Opdenakker G (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42:113–185PubMedCrossRef
7.
go back to reference Murphy G, Knauper V (1997) Relating matrix metalloproteinase structure to function: why the “hemopexin” domain? Matrix Biol 15:511–518PubMedCrossRef Murphy G, Knauper V (1997) Relating matrix metalloproteinase structure to function: why the “hemopexin” domain? Matrix Biol 15:511–518PubMedCrossRef
8.
go back to reference McCawley LJ, Matrisian LM (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6:149–156PubMedCrossRef McCawley LJ, Matrisian LM (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6:149–156PubMedCrossRef
9.
go back to reference Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR (1991) Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumors. Int J Cancer 49:666–672PubMedCrossRef Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR (1991) Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumors. Int J Cancer 49:666–672PubMedCrossRef
10.
go back to reference Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst (Bethesda) 89:1260–1270 Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst (Bethesda) 89:1260–1270
11.
go back to reference Murray G, Duncan ME, O’Neil P, Melvin WT, Fothergill JE (1996) Matrix metalloproteinases-1 is associated with poor prognosis in colorectal cancer. Nat Med 2:461–462PubMedCrossRef Murray G, Duncan ME, O’Neil P, Melvin WT, Fothergill JE (1996) Matrix metalloproteinases-1 is associated with poor prognosis in colorectal cancer. Nat Med 2:461–462PubMedCrossRef
12.
go back to reference Murray GI, Duncan ME, O’Neil P, McKay JA, Melvin WT, Fothergill JE (1998) Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer. Gut 35:599–603CrossRef Murray GI, Duncan ME, O’Neil P, McKay JA, Melvin WT, Fothergill JE (1998) Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer. Gut 35:599–603CrossRef
13.
go back to reference Woo M, Park K, Nam J, Kim JC (2007) Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 22:1064–1070PubMedCrossRef Woo M, Park K, Nam J, Kim JC (2007) Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 22:1064–1070PubMedCrossRef
14.
go back to reference Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A, Koksal V (2008) A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. BJU Int 101:503–507PubMed Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A, Koksal V (2008) A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. BJU Int 101:503–507PubMed
15.
go back to reference Shimizu Y, Kondo S, Shirai A, Furukawa M, Yoshizaki T (2008) A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 35:381–389PubMedCrossRef Shimizu Y, Kondo S, Shirai A, Furukawa M, Yoshizaki T (2008) A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 35:381–389PubMedCrossRef
16.
go back to reference Nishizawa R, Nagata M, Noman AA, Kitamura N, Fujita H, Hoshina H, Kubota T, Itagaki M, Shingaki S, Ohnishi M, Kurita H, Katsura K, Saito C, Yoshie H, Takagi R (2007) The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma. BMC Cancer 7:187PubMedCrossRef Nishizawa R, Nagata M, Noman AA, Kitamura N, Fujita H, Hoshina H, Kubota T, Itagaki M, Shingaki S, Ohnishi M, Kurita H, Katsura K, Saito C, Yoshie H, Takagi R (2007) The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma. BMC Cancer 7:187PubMedCrossRef
17.
go back to reference Nasr HB, Mestiri S, Chahed K, Bouaouina N, Gabbouj S, Jalbout M, Couchane L (2007) Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Clin Chim Acta 384:57–63PubMedCrossRef Nasr HB, Mestiri S, Chahed K, Bouaouina N, Gabbouj S, Jalbout M, Couchane L (2007) Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Clin Chim Acta 384:57–63PubMedCrossRef
18.
go back to reference Zinzindohoue F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P (2005) Prognostic signifi cance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clin Cancer Res 11:594–599PubMed Zinzindohoue F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P (2005) Prognostic signifi cance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clin Cancer Res 11:594–599PubMed
19.
go back to reference Cao ZG, Li CZ (2006) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 42:32–38PubMedCrossRef Cao ZG, Li CZ (2006) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population. Oral Oncol 42:32–38PubMedCrossRef
20.
go back to reference Nishioka Y, Sagae S, Nishikawa A, Ishioka S, Kudo R (2003) A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett 200:49–55PubMedCrossRef Nishioka Y, Sagae S, Nishikawa A, Ishioka S, Kudo R (2003) A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett 200:49–55PubMedCrossRef
21.
go back to reference Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, Terakawa N, Nakamura Y (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225–4227PubMed Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, Terakawa N, Nakamura Y (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225–4227PubMed
22.
go back to reference Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC (2006) Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis 27:1024–1029PubMedCrossRef Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC (2006) Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis 27:1024–1029PubMedCrossRef
23.
go back to reference McCready J, Broaddus WC, Sykes V, Fillmore HL (2005) Association of a single nucleotide polymorphism in the matrix metalloproteinase-1 promoter with glioblastoma. Int J Cancer 117:781–785PubMedCrossRef McCready J, Broaddus WC, Sykes V, Fillmore HL (2005) Association of a single nucleotide polymorphism in the matrix metalloproteinase-1 promoter with glioblastoma. Int J Cancer 117:781–785PubMedCrossRef
24.
go back to reference Lu Z, Cao Y, Wang Y, Zhang Q, Zhang X, Wang S, Li Y, Xie H, Jiao B, Zhang J (2007) Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. J Neurooncol 85:65–73PubMedCrossRef Lu Z, Cao Y, Wang Y, Zhang Q, Zhang X, Wang S, Li Y, Xie H, Jiao B, Zhang J (2007) Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. J Neurooncol 85:65–73PubMedCrossRef
25.
go back to reference Fillmore HL, Van Meter T, Broaddus WC (2001) Membrane type metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neuro-Oncol 53:187–202CrossRef Fillmore HL, Van Meter T, Broaddus WC (2001) Membrane type metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neuro-Oncol 53:187–202CrossRef
26.
go back to reference Van Meter T, Rooprai HK, Kibble MM, Fillmore HL, Broaddus WC, Pilkington GJ (2001) The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neuro-Oncol 53:213–235CrossRef Van Meter T, Rooprai HK, Kibble MM, Fillmore HL, Broaddus WC, Pilkington GJ (2001) The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neuro-Oncol 53:213–235CrossRef
27.
go back to reference Rao J, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta L, Sawaya R (1994) Role of plasminogen activator and of 92- Kda type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neuro-Oncol 18:129–138CrossRef Rao J, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta L, Sawaya R (1994) Role of plasminogen activator and of 92- Kda type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neuro-Oncol 18:129–138CrossRef
28.
go back to reference Rooprai HK, Van Meter T, Rucklidge GJ, Hudson L, Everall IP, Pilkington GJ (1998) Comparative analysis of matrix metalloproteinases by immunocytochemistry, immuno-histochemistry and zymography in human primary brain tumors. International J Oncol 13:153–157 Rooprai HK, Van Meter T, Rucklidge GJ, Hudson L, Everall IP, Pilkington GJ (1998) Comparative analysis of matrix metalloproteinases by immunocytochemistry, immuno-histochemistry and zymography in human primary brain tumors. International J Oncol 13:153–157
29.
go back to reference Rutka JT, Matsuzawa K, Hubbard SL, Fukuyama K, Becker L, Stetler-Stevenson WG, Edwards D, Dirks PB (1995) Expression of TIMP-1, TIMP-2, 72-and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with invasiveness. Int J Oncol 6:877–884 Rutka JT, Matsuzawa K, Hubbard SL, Fukuyama K, Becker L, Stetler-Stevenson WG, Edwards D, Dirks PB (1995) Expression of TIMP-1, TIMP-2, 72-and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with invasiveness. Int J Oncol 6:877–884
30.
go back to reference Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao J (1996) Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14:35–42PubMedCrossRef Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao J (1996) Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14:35–42PubMedCrossRef
31.
go back to reference Rao J (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489–501PubMedCrossRef Rao J (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489–501PubMedCrossRef
32.
go back to reference Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix Metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 52:255–264PubMedCrossRef Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix Metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 52:255–264PubMedCrossRef
33.
go back to reference Binder D, Berger M (2002) Proteases and the biology of glioma invasion. J Neuro-Oncol 56:149–158CrossRef Binder D, Berger M (2002) Proteases and the biology of glioma invasion. J Neuro-Oncol 56:149–158CrossRef
34.
go back to reference Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J (1995) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298–307PubMedCrossRef Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J (1995) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298–307PubMedCrossRef
35.
go back to reference Nakagawa T, Kubota T, Masanori Kabuto, Sato K, Kawano H, Hayakawa T, Okada Y (1994) Production of matrix metallooproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81:69–77PubMedCrossRef Nakagawa T, Kubota T, Masanori Kabuto, Sato K, Kawano H, Hayakawa T, Okada Y (1994) Production of matrix metallooproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81:69–77PubMedCrossRef
36.
go back to reference Stojic J, Hagemann C, Haas S, Herbold C, Kühnel S, Gerngras S, Roggendorf W, Roosen K, Vince GH (2008) Expression of matrix metalloproteinases MMP1, MMP11 and MMP19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60:40–49PubMedCrossRef Stojic J, Hagemann C, Haas S, Herbold C, Kühnel S, Gerngras S, Roggendorf W, Roosen K, Vince GH (2008) Expression of matrix metalloproteinases MMP1, MMP11 and MMP19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60:40–49PubMedCrossRef
37.
go back to reference Miller SA, Dykes DD, Polesky HFA (1998) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215CrossRef Miller SA, Dykes DD, Polesky HFA (1998) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215CrossRef
38.
go back to reference Zhu Y, Spitz M, Lei L, Mills G, Wu X (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61:7825–7829PubMed Zhu Y, Spitz M, Lei L, Mills G, Wu X (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61:7825–7829PubMed
39.
go back to reference Brinckerhoff CE, Rutter JL, Benbow U (2000) Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6:4823–4830PubMed Brinckerhoff CE, Rutter JL, Benbow U (2000) Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6:4823–4830PubMed
40.
go back to reference Sternlicht M, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463–516PubMedCrossRef Sternlicht M, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463–516PubMedCrossRef
41.
go back to reference Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321–5325PubMed Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321–5325PubMed
42.
go back to reference Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW (2004) Correlation between functional genotypes in the matrix metalloproteinases- 1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med 33:323–326PubMedCrossRef Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW (2004) Correlation between functional genotypes in the matrix metalloproteinases- 1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med 33:323–326PubMedCrossRef
43.
go back to reference Wenham R, Brian Calingarty, Ali S, McClean K, Whitaker R, Bentley R, Lancaster J, Schildkraut J, Marks J, Berchuck A (2003) Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer. J Soc Gynecol Investig 10:381–387PubMedCrossRef Wenham R, Brian Calingarty, Ali S, McClean K, Whitaker R, Bentley R, Lancaster J, Schildkraut J, Marks J, Berchuck A (2003) Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer. J Soc Gynecol Investig 10:381–387PubMedCrossRef
44.
go back to reference Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, Hinoka Y (2003) A Single Nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer 106:372–374PubMedCrossRef Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, Hinoka Y (2003) A Single Nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer 106:372–374PubMedCrossRef
45.
go back to reference Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, Kanamori Y, Minaguchi T, Nakamura Y, Tokino T, Kudo R (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91:612–615PubMed Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, Kanamori Y, Minaguchi T, Nakamura Y, Tokino T, Kudo R (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91:612–615PubMed
46.
go back to reference Pirhan D, Atilla G, Emingil G, Sorsa T, Tervahartiala T, Berdeli A (2008) Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of periodontal therapy in patients with severe chronic periodontitis. J Clin Periodontol 35:862–870PubMedCrossRef Pirhan D, Atilla G, Emingil G, Sorsa T, Tervahartiala T, Berdeli A (2008) Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of periodontal therapy in patients with severe chronic periodontitis. J Clin Periodontol 35:862–870PubMedCrossRef
47.
go back to reference Flex A, Gaetani E, Angelini F, Sabusco A, Chilla C, Straface G, Biscetti F, Pola P, Castellot JJ Jr, Pola R (2007) Proinflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Int Med 262:124–130CrossRef Flex A, Gaetani E, Angelini F, Sabusco A, Chilla C, Straface G, Biscetti F, Pola P, Castellot JJ Jr, Pola R (2007) Proinflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Int Med 262:124–130CrossRef
48.
go back to reference Song YQ, Ho DW, Karppinen J, Kao PY, Fan BJ, Luk KD, Yip SP, Leong JC, Cheah KS, Sham P, Chan D, Cheung KM (2008) Association between promoter -1607 polymorphism of MMP1 and lumbar disc disease in Southern Chinese. BMC Med Genet 9:38PubMedCrossRef Song YQ, Ho DW, Karppinen J, Kao PY, Fan BJ, Luk KD, Yip SP, Leong JC, Cheah KS, Sham P, Chan D, Cheung KM (2008) Association between promoter -1607 polymorphism of MMP1 and lumbar disc disease in Southern Chinese. BMC Med Genet 9:38PubMedCrossRef
49.
go back to reference Kuo HP, Wang YM, Wang CH, He CC, Lin SM, Lin HC, Liu CY, Huang KH, Hsieh LL, Huang CD (2008) Matrix metalloproteinase-1 polymorphism in Taiwanese patients with endobronchial tuberculosis. Tuberculosis 88:262–267PubMedCrossRef Kuo HP, Wang YM, Wang CH, He CC, Lin SM, Lin HC, Liu CY, Huang KH, Hsieh LL, Huang CD (2008) Matrix metalloproteinase-1 polymorphism in Taiwanese patients with endobronchial tuberculosis. Tuberculosis 88:262–267PubMedCrossRef
50.
go back to reference Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41:209–214PubMedCrossRef Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41:209–214PubMedCrossRef
51.
go back to reference Horne BD, May HT, Anderson JL, Kfoury AG, Bailey BM, McClure BS, Renlund DG, Lappe DL, Carlquist JF, Fisher PW, Pearson RR, Bair TL, Adams TD, Muhlestein JB (2008) Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 102:814–819PubMedCrossRef Horne BD, May HT, Anderson JL, Kfoury AG, Bailey BM, McClure BS, Renlund DG, Lappe DL, Carlquist JF, Fisher PW, Pearson RR, Bair TL, Adams TD, Muhlestein JB (2008) Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 102:814–819PubMedCrossRef
52.
go back to reference Ju W, Kim JW, Park NH, Song YS, Kim SC, Kang SB, Lee HP (2007) Matrix metalloproteinase-1 promoter polymorphism and epithelial ovarian cancer: does ethnicity matter? J Obstet Gynaecol Res 33:155–160PubMedCrossRef Ju W, Kim JW, Park NH, Song YS, Kim SC, Kang SB, Lee HP (2007) Matrix metalloproteinase-1 promoter polymorphism and epithelial ovarian cancer: does ethnicity matter? J Obstet Gynaecol Res 33:155–160PubMedCrossRef
Metadata
Title
Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population
Authors
Nitin Malik
Raj Kumar
Kashi N. Prasad
Priyanka Kawal
Arun Srivastava
Ashok K. Mahapatra
Publication date
01-05-2011
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2011
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-010-0337-z

Other articles of this Issue 3/2011

Journal of Neuro-Oncology 3/2011 Go to the issue